Argyle Capital Management Inc. Teva Pharmaceutical Industries LTD Transaction History

Argyle Capital Management Inc.

$248 Million
Q3 2024

A detailed history of Argyle Capital Management Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Argyle Capital Management Inc. holds 16,200 shares of TEVA stock, worth $283,500. This represents 0.12% of its overall portfolio holdings.

Number of Shares

16,200

Previous 16,200 -0.0%

Holding current value

$283,500

Previous $263,000 10.65%

% of portfolio

0.12%

Previous 0.11%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$12.78 - $17.4 $17,892 - $24,359	-1,400 Reduced 7.95%	16,200 $263,000
Q1 2024 Apr 29, 2024	SELL	$10.67 - $14.43 $15,471 - $20,923	-1,450 Reduced 7.61%	17,600 $248,000
Q4 2023 Feb 05, 2024	SELL	$8.12 - $10.63 $95,815 - $125,434	-11,800 Reduced 38.25%	19,050 $198,000
Q2 2023 Jul 27, 2023	SELL	$7.2 - $9.47 $10,800 - $14,205	-1,500 Reduced 4.64%	30,850 $232,000
Q3 2022 Oct 21, 2022	SELL	$6.86 - $11.95 $686 - $1,195	-100 Reduced 0.31%	32,350 $261,000
Q1 2022 Apr 27, 2022	SELL	$7.33 - $9.39 $733 - $939	-100 Reduced 0.31%	32,450 $305,000
Q4 2021 Jan 25, 2022	SELL	$7.9 - $10.19 $73,470 - $94,767	-9,300 Reduced 22.22%	32,550 $261,000
Q3 2021 Oct 25, 2021	SELL	$8.38 - $10.18 $14,246 - $17,306	-1,700 Reduced 3.9%	41,850 $408,000
Q4 2020 Jan 28, 2021	SELL	$8.61 - $11.04 $5,166 - $6,623	-600 Reduced 1.36%	43,550 $420,000
Q3 2020 Oct 27, 2020	SELL	$8.57 - $12.69 $6,856 - $10,152	-800 Reduced 1.78%	44,150 $398,000
Q4 2019 Jan 24, 2020	SELL	$6.53 - $10.72 $47,342 - $77,720	-7,250 Reduced 13.89%	44,950 $441,000
Q3 2019 Oct 25, 2019	SELL	$6.16 - $9.6 $34,496 - $53,760	-5,600 Reduced 9.69%	52,200 $359,000
Q4 2018 Jan 28, 2019	BUY	$14.59 - $23.84 $14,590 - $23,840	1,000 Added 1.76%	57,800 $891,000
Q3 2018 Oct 26, 2018	SELL	$21.06 - $25.65 $42,120 - $51,300	-2,000 Reduced 3.4%	56,800 $1.22 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $16,770 - $24,710	-1,000 Reduced 1.67%	58,800 $1.43 Million
Q1 2018 Apr 25, 2018	SELL	$16.68 - $22.07 $15,846 - $20,966	-950 Reduced 1.56%	59,800 $1.02 Million
Q4 2017 Jan 25, 2018	BUY	$11.23 - $19.1 $40,405 - $68,721	3,598 Added 6.3%	60,750 $1.15 Million
Q3 2017 Oct 26, 2017	BUY	$15.41 - $32.17 $880,712 - $1.84 Million	57,152	57,152 $1.01 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.

Account

Argyle Capital Management Inc. Teva Pharmaceutical Industries LTD Transaction History